Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078556427> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2078556427 endingPage "1946" @default.
- W2078556427 startingPage "1941" @default.
- W2078556427 abstract "Clinicians might be misled in interpreting an elevated CA19-9 when differentiating pancreaticobiliary cancer from benign clinical conditions such as acute cholangitis or cholestasis, because in these conditions, the concentration of CA19-9 may also be elevated. The aims of our study were to calculate new individual cutoff values for CA19-9 according to clinical situations using a receiver operating characteristic (ROC) curve and to define a new strategy for interpreting CA19-9 in pancreaticobiliary cancer.One hundred sixty patients with pancreatic diseases (cancer 90, benign disease 70), 322 patients with biliary tract diseases (biliary cancer 152, benign disease 170), and 20,035 asymptomatic controls were enrolled in the present study. An ROC curve was described by plotting the sensitivity on the y-axis against 1-specificity on the x-axis for each of several cutoff values.The area under the ROC curve was significantly greater for pancreatic cancer than for biliary cancer (p < 0.05). For patients with pancreatic cancer, CA19-9 proved to be useful. At a cutoff value of 37 U/ml, sensitivity and specificity were 76.7% and 87.1%, respectively. For patients with biliary cancer, CA19-9 was not helpful. However, when patients with biliary disease were divided into two groups according to the presence of cholangitis or cholestasis, CA19-9 proved to be more useful for the group without cholangitis or cholestasis than for the group with cholangitis or cholestasis (p < 0.05). In the former group, the sensitivity and specificity of CA19-9 were 77.6% and 83%, respectively, at the cutoff value of 37 U/ml. For the latter group, the sensitivity and specificity of CA19-9 were 74% and 41.5% respectively, whereas the specificity reached 87% at 300 U/ml. CA19-9 in diagnosing pancreatic cancer was useful regardless of accompanying acute pancreatitis or cholestasis. The serum concentration of CA19-9 in asymptomatic individuals was 9.42 +/- 9.95 U/ml. Only 1 of 157 patients with a concentration of CA19-9 above 37 U/ml was found to have gallbladder cancer. The positive and negative predictive values were 0.65% and 0.78%, respectively.The use of CA19-9 for the differentiation of pancreaticobiliary cancer should be applied individually, depending on the clinical situation." @default.
- W2078556427 created "2016-06-24" @default.
- W2078556427 creator A5000897017 @default.
- W2078556427 creator A5040217028 @default.
- W2078556427 creator A5044806903 @default.
- W2078556427 creator A5066391689 @default.
- W2078556427 creator A5074108467 @default.
- W2078556427 creator A5076033549 @default.
- W2078556427 creator A5076913063 @default.
- W2078556427 creator A5081957504 @default.
- W2078556427 creator A5087410193 @default.
- W2078556427 date "1999-07-01" @default.
- W2078556427 modified "2023-10-16" @default.
- W2078556427 title "A New Strategy for The Application of Ca19-9 in The Differentiation of Pancreaticobiliary Cancer: Analysis Using A Receiver Operating Characteristic Curve" @default.
- W2078556427 cites W1917001209 @default.
- W2078556427 cites W2003211608 @default.
- W2078556427 cites W2044863052 @default.
- W2078556427 cites W2061879846 @default.
- W2078556427 cites W2073948680 @default.
- W2078556427 cites W2074719822 @default.
- W2078556427 cites W2078837657 @default.
- W2078556427 cites W2087989675 @default.
- W2078556427 doi "https://doi.org/10.1111/j.1572-0241.1999.01234.x" @default.
- W2078556427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10406263" @default.
- W2078556427 hasPublicationYear "1999" @default.
- W2078556427 type Work @default.
- W2078556427 sameAs 2078556427 @default.
- W2078556427 citedByCount "173" @default.
- W2078556427 countsByYear W20785564272012 @default.
- W2078556427 countsByYear W20785564272013 @default.
- W2078556427 countsByYear W20785564272014 @default.
- W2078556427 countsByYear W20785564272015 @default.
- W2078556427 countsByYear W20785564272016 @default.
- W2078556427 countsByYear W20785564272017 @default.
- W2078556427 countsByYear W20785564272018 @default.
- W2078556427 countsByYear W20785564272019 @default.
- W2078556427 countsByYear W20785564272020 @default.
- W2078556427 countsByYear W20785564272021 @default.
- W2078556427 countsByYear W20785564272022 @default.
- W2078556427 countsByYear W20785564272023 @default.
- W2078556427 crossrefType "journal-article" @default.
- W2078556427 hasAuthorship W2078556427A5000897017 @default.
- W2078556427 hasAuthorship W2078556427A5040217028 @default.
- W2078556427 hasAuthorship W2078556427A5044806903 @default.
- W2078556427 hasAuthorship W2078556427A5066391689 @default.
- W2078556427 hasAuthorship W2078556427A5074108467 @default.
- W2078556427 hasAuthorship W2078556427A5076033549 @default.
- W2078556427 hasAuthorship W2078556427A5076913063 @default.
- W2078556427 hasAuthorship W2078556427A5081957504 @default.
- W2078556427 hasAuthorship W2078556427A5087410193 @default.
- W2078556427 hasConcept C121332964 @default.
- W2078556427 hasConcept C121608353 @default.
- W2078556427 hasConcept C126322002 @default.
- W2078556427 hasConcept C144369459 @default.
- W2078556427 hasConcept C2775955815 @default.
- W2078556427 hasConcept C2775982439 @default.
- W2078556427 hasConcept C2778217198 @default.
- W2078556427 hasConcept C2778593092 @default.
- W2078556427 hasConcept C2780210213 @default.
- W2078556427 hasConcept C2909874672 @default.
- W2078556427 hasConcept C58471807 @default.
- W2078556427 hasConcept C62520636 @default.
- W2078556427 hasConcept C71924100 @default.
- W2078556427 hasConcept C90924648 @default.
- W2078556427 hasConceptScore W2078556427C121332964 @default.
- W2078556427 hasConceptScore W2078556427C121608353 @default.
- W2078556427 hasConceptScore W2078556427C126322002 @default.
- W2078556427 hasConceptScore W2078556427C144369459 @default.
- W2078556427 hasConceptScore W2078556427C2775955815 @default.
- W2078556427 hasConceptScore W2078556427C2775982439 @default.
- W2078556427 hasConceptScore W2078556427C2778217198 @default.
- W2078556427 hasConceptScore W2078556427C2778593092 @default.
- W2078556427 hasConceptScore W2078556427C2780210213 @default.
- W2078556427 hasConceptScore W2078556427C2909874672 @default.
- W2078556427 hasConceptScore W2078556427C58471807 @default.
- W2078556427 hasConceptScore W2078556427C62520636 @default.
- W2078556427 hasConceptScore W2078556427C71924100 @default.
- W2078556427 hasConceptScore W2078556427C90924648 @default.
- W2078556427 hasIssue "7" @default.
- W2078556427 hasLocation W20785564271 @default.
- W2078556427 hasLocation W20785564272 @default.
- W2078556427 hasOpenAccess W2078556427 @default.
- W2078556427 hasPrimaryLocation W20785564271 @default.
- W2078556427 hasRelatedWork W2009325523 @default.
- W2078556427 hasRelatedWork W2059560004 @default.
- W2078556427 hasRelatedWork W2073948680 @default.
- W2078556427 hasRelatedWork W2078556427 @default.
- W2078556427 hasRelatedWork W2109056488 @default.
- W2078556427 hasRelatedWork W2161510069 @default.
- W2078556427 hasRelatedWork W2771790232 @default.
- W2078556427 hasRelatedWork W2791242126 @default.
- W2078556427 hasRelatedWork W3158892058 @default.
- W2078556427 hasRelatedWork W434643510 @default.
- W2078556427 hasVolume "94" @default.
- W2078556427 isParatext "false" @default.
- W2078556427 isRetracted "false" @default.
- W2078556427 magId "2078556427" @default.
- W2078556427 workType "article" @default.